Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life among Individuals with Alcohol Use Disorder

BACKGROUND. Abstinence and no heavy drinking days are currently the only Food and Drug Administration (FDA) approved endpoints in clinical trials for alcohol use disorder (AUD). Many individuals who fail to meet these criteria may substantially reduce their drinking during treatment and most individ...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Alcohol Clin Exp Res
Главные авторы: Witkiewitz, Katie, Kranzler, Henry R., Hallgren, Kevin A., O’Malley, Stephanie S., Falk, Daniel E., Litten, Raye Z., Hasin, Deborah S., Mann, Karl F., Anton, Raymond F.
Формат: Artigo
Язык:Inglês
Опубликовано: 2018
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6286196/
https://ncbi.nlm.nih.gov/pubmed/30395350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acer.13897
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы